Company UpdateNewspaper Publication
Pharmaceuticals
Span Divergent Ltd
Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 48 filings·Updated 12 Aug 2026
Showing 10 of 48 filings.
12 Aug 20261 filing
11 Aug 20261 filing
ResultFinancial Results
Span Divergent Q1 June 2026: standalone loss; consolidated income ₹130.20 lakh with negative profits
Standalone results
- Total income 30.83 lakh; expenses 46.56 lakh; PBT before exceptional items -15.73.
- Exceptional items -13.20; PAT after tax -4.22; basic EPS -0.06.
- Board approved unaudited results on Aug 11, 2026; results prepared per Ind AS.
- Total comprehensive income -4.71; paid-up equity share capital 726.32.
Consolidated results
- Total income 130.20 lakh; expenses 244.77 lakh; PBT before tax -114.57.
- PAT after tax -118.82; basic EPS -1.64; segment revenues 35.41 (Cashew), 67.14 (Trading).
- Net revenue from operations from segments 102.55; total comprehensive income -119.61.
- Independent auditor's review report indicates no material misstatement.
13 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
RTA confirms processing of dematerialisation requests and listing of dematerialised securities
Dematerialisation status
- RTA processed all dematerialisation requests received in the period within the time limit.
- Dematerialised securities have been listed on the stock exchanges where the earlier issues are listed.
- Physical certificates were mutilated and cancelled; the depository’s name was substituted as registered owner within the timeline.
6 Jul 20261 filing
Company UpdateAward of Order / Receipt of Order
Arbitral Award Against Span Divergent Ltd for ₹24,55,614 Plus Interest by Gujarat High Court Arbitration Centre
Arbitral Award Details
- Awarding entity: The Gujarat High Court Arbitration Centre, Sola, Ahmedabad (India).
- Nature and scope: Arbitral award in employment matter against Span Divergent Ltd, Aranya Agri Biotech LLP, Viral Desai.
- Value: ₹24,55,614 principal plus 12% simple interest from 09-08-2019 to 02-07-2026.
- Award date: 02-07-2026; matter not final; company to challenge remedies available.
- Jurisdiction: Domestic arbitration center located in India.
- Related party involvement: Respondents include Span Divergent Ltd and Viral Desai.
- Impact: Adverse financial impact possible; final outcome depends on legal proceedings.
25 May 20261 filing
Board Meeting
Span Divergent Ltd-$ - 524727 - Board Meeting Intimation for Span Divergent Limited Board Meeting To Be Held On May 30, 2026
Meeting Details
- Board meeting scheduled for Saturday, May 30, 2026.
- Meeting time and location were not disclosed.
Key Agenda Items
- Approve audited standalone and consolidated financial results for quarter and year ended March 31, 2026.
- Review the statutory auditors' report and draft directors' report.
- Consider or recommend dividend for the year ended March 31, 2026.
- Approve appointment of the internal auditor for financial year 2026-2027.
- Decide the date, time, and venue of the 46th Annual General Meeting.
- Approve book closure period for the 46th Annual General Meeting.
- Approve notice convening the 46th Annual General Meeting.
Other Notes
- Trading window closes until 48 hours after results declaration and reopens on June 2, 2026.
17 Apr 20262 filings
OthersFormat of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
OthersFormat of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
9 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Span Divergent Limited - Certificate under Reg 74(5) of SEBI (DP) Regulation, 2018
2 Apr 20262 filings
Insider Trading / SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neev Nirav Jogani
Insider Trading / SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neev Nirav Jogani
Showing 10 of 48 filings